
VitriVax
VitriVax develops thermostable, single-dose vaccine formulations, starting with a single-dose Lyme disease vaccine.
$87M Series B+ ·
Led by F-Prime Capital · Source: thepharmaletter.com
Total raised: $104.25M across 2 sourced rounds
All 3 rounds ↓Signals
VitriVax | 1964 days on the record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $87M | thepharmaletter.com | ||
| Series B+ | $17.25M | vcnewsdaily.com | ||
| Series A | undisclosed | finsmes.com |
Timeline
- Website created
Founders and team
TR
Theodore Randolph Co-founder and CTORG
Robert Garcea Co-Founder and CSOMR
Matt Raider CEORC
Romulo Colindres CEOBS
Bryan Steadman CTODD
Damien Dessis CBO
Investors
AAdjuvant Capitallead investor
FF-Prime Capitallead investor
NNEAlead investor
PPiedmont Capital Investments
RRA Capital Managementlead investor
SSanofi Ventureslead investor
Companies like VitriVax
11nhaler$2.95M · Nov 2026RRivercell$25M Seed · Oct 2026
AAces DiagnosticsSeries A · Oct 2026
LLymeAlertSeed · Jul 2026
PPraetorian Bio$1M Pre Seed · Oct 2026
GGlen Clova Scientific$4.98M Seed · Apr 2024
Other companies backed by F-Prime Capital
BBoltz$110M Series A · Nov 2026
TT-Therapeutics$133M Series B+ · Nov 2026
EEka Robotics$150M Series A · Oct 2026
AAblePay Health$20M Series A · Oct 2026
AArboretum$30M Series A · Oct 2026
RR1 Therapeutics$80.5M Series A · Sep 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/vitrivax (get a free API key).